Healthcare Sales & Marketing Network News: Symbyax

Searching News Database: Symbyax

HSMN NewsFeed - 6 Jul 2021
Delix Therapeutics Expands Executive Leadership Team
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 11 Feb 2013
Repros Therapeutics Corporate Update
Biopharmaceuticals FDA Personnel

HSMN NewsFeed - 23 Mar 2009
FDA Approves Symbyax(R) as First Medication for Treatment-Resistant Depression
Biopharmaceuticals FDA

HSMN NewsFeed - 5 Oct 2007
Lilly Announces Updates to the Zyprexa and Symbyax U.S. Labels
Biopharmaceuticals

HSMN NewsFeed - 23 May 2006
New Study Suggests Symbyax(R) Significantly Improves Symptoms of Treatment-Resistant Depression
Biopharmaceuticals

HSMN NewsFeed - 22 May 2006
First Head-to-Head Study Suggests Significantly Greater Symptom Improvement for Symbyax(R) Compared to Lamotrigine in Bipolar Depression
Biopharmaceuticals

Return to NewsFeed

Additional items found! 11

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 11 additional stories matching:
Symbyax
(Password required)

FindReps - Find Great Medical Independent Sales Reps without recruiter fees.

FindReps - available on the Apple App Store for iPhone and iPad.